__NUXT_JSONP__("/drugs/Anti-Globo_H_Monoclonal_Antibody_OBI-888", (function(a,b,c,d){return {data:[{drug:{slug:b,emaEpar:[],fdaDrugLabel:[],id:b,nciThesaurus:{casRegistry:a,chebiId:a,chemicalFormula:a,definition:"A monoclonal antibody targeting the hexasaccharide glycosphingolipid antigen Globo H with potential immunostimulating, anti-angiogenic and antineoplastic activities. Upon infusion, anti-Globo H monoclonal antibody OBI-888 may induce tumor cell destruction via the activation of antibody dependent cell-mediated cytotoxicity (ADCC), antibody-dependent cellular phagocytosis (ADCP) and complement-dependent cytotoxicity (CDC), and may reduce immunosuppression. Globo H is a tumor-associated antigen (TAA) expressed on the surface of various types of cancer cells.",fdaUniiCode:"JI5TBH62QP",identifier:"C153261",preferredName:c,semanticType:"Pharmacologic Substance",subclassOf:["C129822","C1742","C20401"],synonyms:[c,"OBI 888","OBI-888","OBI888"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FAnti-Globo_H_Monoclonal_Antibody_OBI-888",extension:".json",createdAt:d,updatedAt:d}}],fetch:{},mutations:void 0}}("","Anti-Globo_H_Monoclonal_Antibody_OBI-888","Anti-Globo H Monoclonal Antibody OBI-888","2021-10-30T13:34:01.223Z")));